Home » Topics » BioWorld

BioWorld
RSS

ADEZA SWAPS ASSAY RIGHTS FOR FUNDING

Jan. 7, 1992

IMMUNEX PRESIDENT PREDICTS LOWER EARNINGS

Jan. 7, 1992

SOMATOGEN GETS BRITISH PATENT

Jan. 7, 1992

VERTEX GETS SBIR FOR DRUG RESEARCH

Jan. 6, 1992

IMMUNOMEDICS FILES FOR OFFERING

Jan. 6, 1992

APPOINTMENTS AND ADVANCEMENTS

Jan. 6, 1992

REPLIGEN ACQUIRES MANUFACTURING FACILITY

Jan. 6, 1992

THE YEAR AHEAD: HOT MARKET FUELS BARGAINING POWER

Jan. 6, 1992

LIPOSOME CO. ISSUES PATENT WARNING

Jan. 6, 1992

THE YEAR AHEAD: ANALYSTS MAKE THEIR PICKS

Jan. 3, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...